Source: Vascular Pharmacology. Unidades: FMRP, EERP
Subjects: ANTIDEPRESSIVOS (EFEITOS ADVERSOS), ENDOTÉLIO VASCULAR (EFEITOS DE DROGAS), ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMPLICIO, Janaina A et al. Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment. Vascular Pharmacology, v. 73, p. 124-137, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.vph.2015.06.015. Acesso em: 06 jul. 2024.APA
Simplicio, J. A., Resstel, L. B. M., Tirapelli, D. P. da C., D'Orléans-Juste, P., & Tirapelli, C. R. (2015). Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment. Vascular Pharmacology, 73, 124-137. doi:10.1016/j.vph.2015.06.015NLM
Simplicio JA, Resstel LBM, Tirapelli DP da C, D'Orléans-Juste P, Tirapelli CR. Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment [Internet]. Vascular Pharmacology. 2015 ; 73 124-137.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.vph.2015.06.015Vancouver
Simplicio JA, Resstel LBM, Tirapelli DP da C, D'Orléans-Juste P, Tirapelli CR. Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment [Internet]. Vascular Pharmacology. 2015 ; 73 124-137.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1016/j.vph.2015.06.015
